WPP was added to Sanofi's creative agency roster and GroupM's Mindshare is the drugmaker's new global media agency of record.
What's holding back value-based pricing deals from moving beyond the pilot phase?
The copywriter and the art director come together to inform, spark hope, and create a path forward.
Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug
Express Scripts to limit opioid coverage; Novo's diabetes drug lowers glucose levels in trial; startup aims to give doctors access to a patient's total costs
The lobbying group said it's unclear what the agency's goal is with this research and how it promotes public health.
Prescription rates dramatically decreased following the price hikes of Valeant's Isuprel and Nitropress in 47 hospitals.
Johnson & Johnson has breached the U.K.'s drug regulation code in three places in promotions for smoking cessation product Nicorette.
Gottlieb criticizes drugmakers for 'gaming the system' on generics; investors ignore Trump's pharma criticism; docs are more supportive of single payer
Both positions were newly created as the agency has grown over the past year.
Pfizer accuses J&J of limiting biosimilar uptake; Trump again criticizes high drug prices; WebMD to reposition site to help consumers manage their health
Merck CEO leaves Trump's manufacturing council over Charlottesville response; researchers struggle to fill clinical trials for IO drugs; Roche shareholders sue over top-line results
Calman is joining the technology company as VP of comms for Watson Health.
The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.
The goal is to further cement point of care as a mainstream media channel.
Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.
Egalet slashes workforce in favor of opioid education; Novo's experimental obesity drug reports positive results; Trump declares opioid crisis a national emergency
One in 12 docs took payments from opioid makers; hospitals cut use of Isuprel and Nitropress after price hikes; AI helping develop ALS drugs